OptimizeRx Corporation Common Stock (OPRX) is a publicly traded Healthcare sector company. As of May 21, 2026, OPRX trades at $4.97 with a market cap of $95.51M and a P/E ratio of 17.54. OPRX moved +3.00% today. Year to date, OPRX is -62.26%; over the trailing twelve months it is -58.41%. Its 52-week range spans $3.78 to $22.25. Analyst consensus is strong buy with an average price target of $12.00. Rallies surfaces OPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OptimizeRx Corporation Common Stock (OPRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. OPRX moved +3.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $4.97 |
| Market Cap | $95.51M |
| P/E Ratio | 17.54 |
| EPS | $0.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.25 |
| 52-Week Low | $3.78 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $109.43M |
| Net Income | $5.13M |
| Gross Margin | 67.25% |
6 analysts cover OPRX: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.00.